How Tanshinone IIA Helps Heart Cells Recover from Injury
Author Information
Author(s): Sang Yiwei, Du Jiangnan, Zulikala Dilimulati, Sang Zhongqiang
Primary Institution: Queen’s University Belfast, Belfast, United Kingdom
Hypothesis
Tanshinone IIA influences myocardial ischemia-reperfusion injury through the ATM/GADD45/ORC signaling pathway.
Conclusion
Tanshinone IIA can relieve myocardial ischemia-reperfusion injury in cardiac cells by activating the ATM/GADD45/ORC pathway.
Supporting Evidence
- Tanshinone IIA treatment improved cell viability in H9C2 cells after ischemia-reperfusion injury.
- Significant reductions in cardiac biomarkers CK, AST, and LDH were observed with Tanshinone IIA treatment.
- Transcriptomic analysis revealed that Tanshinone IIA affects genes involved in the cell cycle and DNA repair.
Takeaway
Tanshinone IIA is like a superhero for heart cells, helping them heal after being hurt by a lack of oxygen and blood.
Methodology
The study used H9C2 cardiac myoblast cells, which were treated with Tanshinone IIA after inducing ischemia-reperfusion injury, and various assays were performed to assess cell viability and gene expression.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website